Literature DB >> 25034241

Gender differences in the relationship between plasma lipids and fasting plasma glucose in non-diabetic urban Chinese population: a cross-section study.

Jie Zheng1, Yuzhen Gao, Yuejuan Jing, Xiaoshuang Zhou, Yuanyuan Shi, Yanhong Li, Lihua Wang, Ruiying Wang, Maolian Li, Chuanshi Xiao, Yafeng Li, Rongshan Li.   

Abstract

The association between dyslipidemia and elevated fasting glucose in type 2 diabetes is well known. In non-diabetes, whether this association still exists, and whether dyslipidemia is an independent risk factor for high fasting plasma glucose (FPG) levels are not clear. This cross-sectional study recruited 3460 non-diabetic Chinese subjects (1027 men, and 2433 women, aged 35-75 years old) who participated in a health survey. Men and women were classified into tertiles by levels of plasma lipids respectively. In women, the prevalence of impaired fasting glucose (IFG) was decreased with increased HDL-C. A stepwise increase in HDL-C was associated with decreasing FPG levels (lowest tertiles, FPG: 5.376 ± 0.018; middle tertiles, 5.324 ± 0.018; highest tertiles, 5.276 ± 0.018 mmol/L; P = 0.001). Reversely, FPG levels increased from lowest tertiles to highest tertiles of LDL-C, TC, and TG. we found that women in the first tertile with lower HDL-C level had a 1.75-fold increase in risk of IFG compared with non-diabetic women in the third tertile with higher HDL-C level (OR: 1.75; 95% CI: 1.20-2.56). In men, no significant association was found. We took age, BMI, waist/hip ratio, education, smoking, alcohol drinking, and physical exercise as adjusted variables. In Chinese non-diabetic women, dyslipidemia is independently associated with high levels of FPG; TG, HDL-C, and LDL-C are predictors of IFG independent of BMI and waist/hip ratio.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25034241     DOI: 10.1007/s11684-014-0346-y

Source DB:  PubMed          Journal:  Front Med        ISSN: 2095-0217            Impact factor:   4.592


  24 in total

1.  Cardiovascular risk factors in confirmed prediabetic individuals. Does the clock for coronary heart disease start ticking before the onset of clinical diabetes?

Authors:  S M Haffner; M P Stern; H P Hazuda; B D Mitchell; J K Patterson
Journal:  JAMA       Date:  1990-06-06       Impact factor: 56.272

2.  Changes in serum lipids and postprandial glucose and insulin concentrations after consumption of beverages with beta-glucans from oats or barley: a randomised dose-controlled trial.

Authors:  M Biörklund; A van Rees; R P Mensink; G Onning
Journal:  Eur J Clin Nutr       Date:  2005-11       Impact factor: 4.016

3.  A prospective study of maturity-onset diabetes mellitus and risk of coronary heart disease and stroke in women.

Authors:  J E Manson; G A Colditz; M J Stampfer; W C Willett; A S Krolewski; B Rosner; R A Arky; F E Speizer; C H Hennekens
Journal:  Arch Intern Med       Date:  1991-06

Review 4.  Management of diabetic dyslipidemia.

Authors:  Maria Del Pilar Solano; Ronald B Goldberg
Journal:  Endocrinol Metab Clin North Am       Date:  2005-03       Impact factor: 4.741

Review 5.  Obesity-related changes in high-density lipoprotein metabolism.

Authors:  Arshag D Mooradian; Michael J Haas; Kent R Wehmeier; Norman C W Wong
Journal:  Obesity (Silver Spring)       Date:  2008-04-03       Impact factor: 5.002

6.  Lipids, diabetes, and coronary heart disease: insights from the Framingham Study.

Authors:  W B Kannel
Journal:  Am Heart J       Date:  1985-11       Impact factor: 4.749

7.  Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation.

Authors:  K G Alberti; P Z Zimmet
Journal:  Diabet Med       Date:  1998-07       Impact factor: 4.359

Review 8.  Dyslipidemia in type 2 diabetes mellitus.

Authors:  Arshag D Mooradian
Journal:  Nat Clin Pract Endocrinol Metab       Date:  2009-03

9.  Inhibition of apolipoprotein AI gene expression by tumor necrosis factor alpha: roles for MEK/ERK and JNK signaling.

Authors:  Ann Beers; Michael J Haas; Norman C W Wong; Arshag D Mooradian
Journal:  Biochemistry       Date:  2006-02-21       Impact factor: 3.162

Review 10.  Insulin resistance, inflammation, and the prediabetic state.

Authors:  Steven M Haffner
Journal:  Am J Cardiol       Date:  2003-08-18       Impact factor: 2.778

View more
  5 in total

1.  Increasing glycaemia is associated with a significant decline in HDL cholesterol in women with prediabetes in two national populations.

Authors:  Chaiwat Washirasaksiri; Weerachai Srivanichakorn; Ian F Godsland; Chayanis Kositamongkol; Suwat Chariyalertsak; Pattapong Kessomboon; Sawitri Assanangkornchai; Surasak Taneepanichskul; Nareemarn Neelapaichit; Pochamana Phisalprapa; Desmond G Johnston; Nick S Oliver; Wichai Aekplakorn
Journal:  Sci Rep       Date:  2021-06-09       Impact factor: 4.379

2.  A Higher Serum Anion Gap Is Associated with the Risk of Progressing to Impaired Fasting Glucose and Diabetes.

Authors:  Yingchao Zhang; Fengran Xiong; Ruxuan Zhao; Tingting Shi; Jing Lu; Jinkui Yang
Journal:  Int J Endocrinol       Date:  2021-12-13       Impact factor: 3.257

3.  Relationships between fasting glucose levels, lifestyle factors, and metabolic parameters in Korean adults without diagnosis of diabetes mellitus.

Authors:  Seo Young Kang; Young Sik Kim
Journal:  J Diabetes       Date:  2021-12-03       Impact factor: 4.530

4.  Factors associated with pre-diabetes in Tehranian men and women: A structural equations modeling.

Authors:  Parisa Amiri; Sara Jalali-Farahani; Mehrdad Karimi; Reza Taherian; Sara Kazempour-Ardebili; Firoozeh Hosseini-Esfahani; Parvin Mirmiran; Fereidoun Azizi
Journal:  PLoS One       Date:  2017-12-07       Impact factor: 3.240

5.  Cardiometabolic risk factors in Thai individuals with prediabetes treated in a high-risk, prevention clinic: Unexpected relationship between high-density lipoprotein cholesterol and glycemia in men.

Authors:  Weerachai Srivanichakorn; Ian F Godsland; Chaiwat Washirasaksiri; Pochamana Phisalprapa; Phunchai Charatcharoenwitthaya; Pornpoj Pramyothin; Tullaya Sitasuwan; Lukana Preechasuk; Robert Elkeles; K George Mm Alberti; Desmond G Johnston; Nick S Oliver
Journal:  J Diabetes Investig       Date:  2018-11-30       Impact factor: 4.232

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.